UNSPSC 51332520: Haloperidol lactate

This classification denotes a dopamine antagonist with the molecular formula C21H23ClFNO2.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6387S86PK3, chemically known as 1-butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)- but more generally known as haloperidol lactate, which bears US NIH Compound Identifier 3559. European Medicines Agency schedules Haloperidol lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02453MIG.

UNSPSC 51332520 Haloperidol lactate is a Commodity code, but the recent state and local procurement activity under this code does not align with its nominal pharmaceutical scope. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, soliciting naloxone and safe drug deactivation systems — neither of which is haloperidol lactate. The mismatch suggests either a tagging error in the county's procurement system or a deliberate use of the code to cast a wider net within pharmaceutical and medical-supply categories. State and local buyers using this code appear to be county health departments and community health agencies focused on opioid-response and harm-reduction supplies rather than antipsychotic medications. The procurement structure — annual unit quantities with quarterly deliveries, fixed pricing, and multi-year terms with renewal options — is typical of recurring county health supply contracts.

Seminole County represents the only recent opportunity visible under this code. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to its community health building in Sanford, Florida. The IFB closed July 26, 2023 (note: the due date in the source predates the posting date by approximately three years, likely a data-entry error). Vendors were required to submit electronic bids through Seminole County's e-Procurement Portal, include all shipping and delivery costs, and meet drug-free workplace and E-Verify compliance. The initial contract term was two years with one optional renewal year. FEMA funding was noted as a potential source, which triggers additional federal compliance requirements. The lack of explicit set-aside designations suggests open competition, though standard local-vendor preferences or SBE programs may apply under Seminole County's purchasing policies. The scarcity of recent opportunities under this code indicates minimal current state and local procurement activity in this specific pharmaceutical category.